Search Drug Information, Interactions, Images, Dosage & Side Effects

Early dietician involvement shortens length of stay in hospitalized patients 27 Jun 2023
There appears to be a weak agreement between nurses and dieticians when screening for malnutrition among patients admitted to hospitals, and this may lead to a much longer stay, reveals a study.

COVID-19 pandemic immensely impacts mental health in postnatal women

27 Jun 2023

Novel genetic marker predicts CHD risk in Chinese patients with T2DM

27 Jun 2023

Watermelon good for the heart

27 Jun 2023

New scorecard helps detect peanut allergy

27 Jun 2023

Plant-based diet may reduce risk of gestational weight gain

26 Jun 2023

Sacituzumab govitecan proven safe, effective in metastatic breast cancer

26 Jun 2023

Symptom-based protocol improves management of anticancer therapy infusion reactions

26 Jun 2023

Debunking the myth: There is no ‘obesity paradox’, new data suggest

26 Jun 2023

Pembrolizumab well tolerated, improves outcomes in NSCLC patients with autoimmune disease

25 Jun 2023

Dolutegravir safe, effective in paediatric HIV

24 Jun 2023

Long COVID: What we have learned so far 27 Apr 2023;

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

RELIFE launches Definisse™, the XTR™ technology backed range of facial fillers in Asia

12 Apr 2023

EMPULSE trial confirms the efficacy and safety profile of empagliflozin in patients stabilized in hospital following acute heart failure

21 Mar 2023

NCDs in Focus Act Now! Summit 2022

16 Mar 2023

Kanjinti

Contents : Trastuzumab

Indications/Uses : Treatment of adult patients w/ HER2 +ve metastatic breast cancer (MBC) as monotherapy in patients who have received at least 2 chemotherapy regimens for their metastatic disease (prior chemotherapy must have included at least an anthracycline & a taxane unless patients are unsuitable for these treatments; hormone-receptor +ve patients must also have failed hormonal therapy, unless patients are unsuitable for these treatments); in combination w/ paclitaxel for patients who have not received chemotherapy for their metastatic disease & for whom an anthracycline is not suitable; in combination w/ docetaxel for patients who have not received chemotherapy for their metastatic disease; in combination w/ an aromatase inhibitor for postmenopausal patients w/ hormone-receptor +ve MBC not previously treated w/ trastuzumab. Treatment of adult patients w/ HER2 +ve early breast cancer (EBC) following surgery, chemotherapy (neoadjuvant or adjuvant) & RT if applicable; following adjuvant chemotherapy w/ doxorubicin & cyclophosphamide, in combination w/ paclitaxel or docetaxel; in combination w/ adjuvant chemotherapy consisting of docetaxel & carboplatin; in combination w/ neoadjuvant chemotherapy followed by adjuvant trastuzumab therapy for locally advanced (including inflammatory) disease or tumours >2 cm in diameter. Treatment of adult patients w/ HER2 +ve metastatic adenocarcinoma of the stomach or gastroesophageal junction who have not received prior anticancer treatment for their metastatic disease in combination w/ capecitabine or 5-fluorouracil & cisplatin.

Zyphrine

Contents : Levocetirizine HCl

Indications/Uses : Relief of nasal & ocular symptoms of seasonal & perennial allergic rhinitis. Relief of symptoms of chronic idiopathic urticaria.

Actranex

Contents : Tranexamic acid

Indications/Uses : Treatment & prophylaxis of haemorrhage associated w/ excessive fibrinolysis. Prophylaxis of hereditary angioedema.

Rosuzet

Contents : Per 10/10 mg FC tab Ezetimibe 10 mg, rosuvastatin Ca 10 mg. Per 10/20 mg FC tab Ezetimibe 10 mg, rosuvastatin Ca 20 mg

Indications/Uses : Adjunctive therapy to diet for the reduction of elevated total cholesterol (total-C), LDL-C, Apo B, triglycerides (TG), & non-HDL-C, & to increase HDL-C in patients w/ primary (heterozygous familial & non-familial) hypercholesterolemia or mixed hyperlipidemia. Reduction of elevated total-C & LDL-C levels in patients w/ HoFH.

Pantomide

Contents : Pantoprazole Na sesquihydrate 40 mg, domperidone 30 mg

Indications/Uses : Management of GERD; gastritis, non-ulcer dyspepsia, gastric or duodenal ulcer, dyspepsia, bloating, fullness, belching, NSAID-induced dyspepsia.

Lit+Control+Devicare+(3+variant)_Down-4C-M1_2023

Lit-Control Devicare pH Down

Contents : L-methionine, phytin, vit A, Zn

Indications/Uses : Food supplement specifically recommended for reduction of JJ catheter calcification & infectious lithiasis/struvite.

Lit+Control+Devicare+(3+variant)_4C-UP_M1-2023

Lit-Control Devicare pH Up

Contents : Theobromine, vit, minerals

Indications/Uses : Food supplement specifically recommended for uric acid lithiasis.

Precedex Premix

Contents : Dexmedetomidine HCl (in 0.9% w/v NaCl)

Indications/Uses : Sedation of initially intubated & mechanically ventilated patients during treatment in an intensive care setting. Sedation/anxiolysis of non-intubated patients prior to &/or during surgical & other procedures.

Norpriexia/Norpriexia Forte

Contents : Per Norpriexia FC tab Paracetamol 450 mg, orphenadrine citrate 35 mg. Per Norpriexia Forte FC tab Paracetamol 650 mg, orphenadrine citrate 35 mg

Indications/Uses : Short term treatment of moderate pain, particularly after surgery & fever. Relieve pain due to skeletal muscle spasm. Musculoskeletal & joint disorders.

Mistacor 40/Mistacor 80

Contents : Telmisartan

Indications/Uses : HTN as monotherapy or in combination w/ other antihypertensives.

Mepresone 40

Contents : Methylprednisolone Na succinate

Indications/Uses : Severe erythema multiforme (SJS); bronchial asthma, severe seasonal & perennial allergic rhinitis, angioneurotic edema, anaphylaxis; ulcerative colitis, Crohn's disease; aspiration of gastric contents, fulminating or disseminated TB (w/ appropriate anti-TB chemotherapy); cerebral oedema secondary to cerebral tumour acute exacerbations of multiple sclerosis superimposed on a relapsing-remitting background; TB meningitis (w/ appropriate anti-TB chemotherapy) transplantation.